DukeSpace Home
→
Duke Faculty Scholarship
→
Duke Faculty Articles
→
Browsing Duke Faculty Articles by Duke-affiliated Author

Browsing Duke Faculty Articles by Duke-affiliated Author "Schulman, Kevin Alan"

Now showing items 1-4 of 4

Can prospect theory explain risk-seeking behavior by terminally ill patients?

Rasiel, Emma; Weinfurt, Kevin; Schulman, Kevin (Medical Decision Making, 2005)

Patients with life-threatening conditions sometimes appear to make risky treatment decisions as their condition declines, contradicting the risk-averse behavior predicted by expected utility theory. Prospect theory ...
Consistency of Financial Interest Disclosures in the Biomedical Literature: The Case of Coronary Stents

Weinfurt, Kevin; Seils, Damon; Tzeng, Janice P.; Lin, Li; Schulman, Kevin; Califf, Robert (PUBLIC LIBRARY SCIENCE, 2008)

Background: Disclosure of authors' financial interests has been proposed as a strategy for protecting the integrity of the biomedical literature. We examined whether authors' financial interests were disclosed consistently ...
Economic return of clinical trials performed under the pediatric exclusivity program.

Li, Jennifer. S; Eisenstein, Eric Leo; Grabowski, Henry G.; Reid, Elizabeth. D; Mangum, Barry; Schulman, Kevin Alan; Goldsmith, John V.; Murphy, M. Dianne; Califf, Robert M.; Benjamin, Daniel Kelly Jr. (2007-02-07)

In 1997, Congress authorized the US Food and Drug Administration (FDA) to grant 6-month extensions of marketing rights through the Pediatric Exclusivity Program if industry sponsors complete FDA-requested pediatric trials. ...
STAR 3 Randomized Controlled Trial to Compare Sensor-Augmented Insulin Pump Therapy with Multiple Daily Injections in the Treatment of Type 1 Diabetes: Research Design, Methods, and Baseline Characteristics of Enrolled Subjects

Schulman, Kevin (MARY ANN LIEBERT INC, 2010)

Background: Sensor-augmented pump therapy (SAPT) integrates real-time continuous glucose monitoring (RT-CGM) with continuous subcutaneous insulin infusion (CSII) and offers an alternative to multiple daily injections (MDI). ...